225 related articles for article (PubMed ID: 25119176)
1. Mast cell phenotype in benign and malignant tumors of the prostate.
Globa T; Saptefrţi L; Ceauşu RA; Gaje P; Cimpean AM; Raica M
Pol J Pathol; 2014 Jun; 65(2):147-53. PubMed ID: 25119176
[TBL] [Abstract][Full Text] [Related]
2. Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors.
Shimizu Y; Suga T; Maeno T; Tsukagoshi H; Kawata T; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
Clin Exp Allergy; 2004 Nov; 34(11):1719-24. PubMed ID: 15544596
[TBL] [Abstract][Full Text] [Related]
3. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.
Fukushima H; Ohsawa M; Ikura Y; Naruko T; Sugama Y; Suekane T; Kitabayashi C; Inoue T; Hino M; Ueda M
Histopathology; 2006 Nov; 49(5):498-505. PubMed ID: 17064296
[TBL] [Abstract][Full Text] [Related]
4. The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.
Glajcar A; Szpor J; Pacek A; Tyrak KE; Chan F; Streb J; Hodorowicz-Zaniewska D; Okoń K
Virchows Arch; 2017 May; 470(5):505-515. PubMed ID: 28315938
[TBL] [Abstract][Full Text] [Related]
5. Tryptase-positive and CD117 Positive Mast Cells Correlate with Survival in Patients with Liver Metastasis.
Giuşcă SE; Căruntu ID; Cîmpean AM; Avadanei RE; Balica AR; Jitariu AA; Raica M
Anticancer Res; 2015 Oct; 35(10):5325-31. PubMed ID: 26408693
[TBL] [Abstract][Full Text] [Related]
6. High density of tryptase-positive mast cells in patients with renal cell carcinoma on hemodialysis: correlation with expression of stem cell factor and protease activated receptor-2.
Watanabe S; Miyata Y; Matsuo T; Mochizuki Y; Nishikido M; Hayashi T; Sakai H
Hum Pathol; 2012 Jun; 43(6):888-97. PubMed ID: 22204707
[TBL] [Abstract][Full Text] [Related]
7. Human mast cells arise from a common circulating progenitor.
Maaninka K; Lappalainen J; Kovanen PT
J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567
[TBL] [Abstract][Full Text] [Related]
8. Number of pericryptal fibroblasts correlates with density of distinct mast cell phenotypes in the crypt lamina propria of human duodenum: implications for the homeostasis of villous architecture.
Crivellato E; Finato N; Isola M; Pandolfi M; Ribatti D; Beltrami CA
Anat Rec A Discov Mol Cell Evol Biol; 2006 Jun; 288(6):593-600. PubMed ID: 16652353
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of mast cells in reflux nephropathy.
Solari V; Unemoto K; Piaseczna Piotrowska A; Puri P
Pediatr Nephrol; 2004 Feb; 19(2):157-63. PubMed ID: 14677055
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions.
Kankkunen JP; Harvima IT; Naukkarinen A
Int J Cancer; 1997 Jul; 72(3):385-8. PubMed ID: 9247277
[TBL] [Abstract][Full Text] [Related]
11. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
Li L; Meng XW; Krilis SA
J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content.
Weidner N; Austen KF
Pathol Res Pract; 1993 Mar; 189(2):156-62. PubMed ID: 8321743
[TBL] [Abstract][Full Text] [Related]
13. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
14. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.
Gulubova MV
Clin Exp Metastasis; 2003; 20(7):611-20. PubMed ID: 14669792
[TBL] [Abstract][Full Text] [Related]
15. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.
Tetlow LC; Woolley DE
Ann Rheum Dis; 1995 Jul; 54(7):549-55. PubMed ID: 7668897
[TBL] [Abstract][Full Text] [Related]
16. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
[TBL] [Abstract][Full Text] [Related]
17. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.
Akimoto S; Ishikawa O; Igarashi Y; Kurosawa M; Miyachi Y
Br J Dermatol; 1998 Mar; 138(3):399-406. PubMed ID: 9580789
[TBL] [Abstract][Full Text] [Related]
18. Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium.
Yadav A; Desai RS; Bhuta BA; Singh JS; Mehta R; Nehete AP
PLoS One; 2014; 9(5):e98719. PubMed ID: 24874976
[TBL] [Abstract][Full Text] [Related]
19. A positive correlation between immunohistochemical expression of CD31 and mast cell tryptase in odontogenic tumors.
Kouhsoltani M; Halimi M; Dibazar S
Pol J Pathol; 2015 Jun; 66(2):170-5. PubMed ID: 26247531
[TBL] [Abstract][Full Text] [Related]
20. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
